Transcription factors in the control of dendritic cell life cycle

Immunologic Research

Volumn 37, Issue 1, 2007, Pages 79-96

  Bharadwaj, Arpita S ^a   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen presentation; Dendritic cells; Ikaros; PU.1; Signaling pathways; Transcription factors

Indexed keywords

CD40 LIGAND; IKAROS TRANSCRIPTION FACTOR; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR; JANUS KINASE 3; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR RELB;

CELL ACTIVATION; CELL CYCLE; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL SURVIVAL; CHROMOSOME 7; DENDRITIC CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 34248345836     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02686091     Document Type: Review

References (106)

1. Inaba K, Inaba M, Deguchi M, et al: Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc Natl Acad Sci USA 1993;90:3038-3042.
2. Banchereau J, Briere F, Caux C, et al: Immunobiology of dendritic cell. Ann Rev Immunol 2000;18:767-811.
3. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998;392:245-252.
4. Bakri Y, Sarrazin S, Mayer UP, et al: Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate. Blood 2005;105(7):2707-2716.
5. Back J, Allman D, Chan S, Kastner P :Visualizing PU.1 activity during hematopoiesis. Exp Hematol 2005;33(4):395-402.
6. Anderson KL, Perkin H, Surh CD,Venturini S, Maki RA, Torbett BE: Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J Immunol 2000;164(4):1855-1861.
7. Guerriero A, Langmuir PB, Spain LM, Scott EW : PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells. Blood 2000;95(3):879-885.
8. Iwama A, Osawa M, Hirasawa R, et al: Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment. J Exp Med 2002;195(5):547-558.
9. Reddy VA, Iwama A, Iotzova G, et al: Granulocyte inducer C/EBPalpha inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions. Blood 2002;100(2):483-490.
10. Wu L, Nichogiannopoulou A, Shortman K, Georgopoulos K : Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity 1997;7(4):483-492.
11. Movassagh M, Laderach D, Galy A : Proteins of the Ikaros family control dendritic cell maturation required to induce optimal Th1 T cell differentiation. Int Immunol 2004;16(6):867-875.
12. Schmitt C, Tonnelle C, Dalloul A, Chabannon C, Debre P, Rebollo A: Aiolos and Ikaros: regulators of lymphocyte development, homeostasis and lymphoproliferation. Apoptosis 2002;7(3):277-284.
13. Yap WH, Yeoh E, Tay A, Brenner S, Venkatesh B: STAT4 is a target of the hematopoietic zinc-finger transcription factor Ikaros in T cells. FEBS Lett 2005;579(20):4470-4478.
14. Gomez-del Arco P, Koipally J, Georgopoulos K: Ikaros SUMOylation: switching out of repression. Mol Cell Biol 2005;25(7):2688-2697.
15. Yamaoka K, Min B, Zhou YJ, Paul WE, O'shea JJ: Jak3 negatively regulates dendritic cell cytokine production and survival. Blood 2005;106(9):3227-3233.
16. Saemann MD, Kelemen P, Zeyda M, Bohmig G, Staffler G, Zlabinger GJ: CD40 triggered human monocyte-derived dendritic cells convert to tolerogenic dendritic cells when JAK3 activity is inhibited. Transplant Proc 2002;34(5):1407-1408.
17. Schotte R, Nagasawa M, Weijer K, Spits H, Blom B : The ETS transcription factor Spi-B is required for human plasmacytoid dendritic cell development. J Exp Med 2004;200(11):1503-1509.
18. Platzer B, Jorgl A, Taschner S, Hocher B, Strobl H: RelB regulates human dendritic cell subset development by promoting monocyte intermediates. Blood 2004;104(12):3655-3663.
19. Anderson KL, Smith KA, Conners K, McKercher SR, Maki RA, Torbett BE: Myeloid development is selectively disrupted in PU.1 null mice. Blood 1998;91(10):3702-3710.
20. Wu L, D'Amico A, Winkel KD, Suter M, Lo D, Shortman K: RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity 1998;9(6):839-847.
21. Pulendran B, Lingappa J, Kennedy MK, et al: Developmental pathways of dendritic cells in vivo: distinct function, phenotype and localization of dendritic cell subset in FLT3 ligand-treated mice. J. Immunol 1997;159: 2222-2231.
22. Vremec D, Shortman K: Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J Immunol 1997;159:565-573.
23. Nakano H, Yanagita M, Gunn MD: CD11c(+)B220(+) Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med 2001;194:1171-1178.
24. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-1118.
25. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O: Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 1998;187:961-966.
26. Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiol Rev 2002;82:97-130.
27. Rathinam C, Geffers R, Yucel R, et al: The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function. Immunity 2005;22(6):717-728.
28. Person RE, Li FQ, Duan Z, et al: Mutations in protooncogene GFI1 cause human neutropenia and target ELA2. Nat Genet 2003;34(3):308-312.
29. Zweidler-Mckay PA, Grimes HL, Flubacher MM, Tsichlis PN: Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol Cell Biol 1996;16(8):4024-4034.
30. Grimes HL, Gilks CB, Chan TO, Porter S, Tsichlis PN: The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death. Proc Natl Acad Sci USA 1996;93(25):14569-14573.
31. Karsunky H, Mende I, Schmidt T, Moroy T: High levels of the onco-protein Gfi-1 accelerate T-cell proliferation and inhibit activation induced T-cell death in Jurkat T-cells. Oncogene 2002;21(10):1571-1579.
32. Schmidt T, Karsunky H, Rodel B, Zevnik B, Elsasser HP, Moroy T: Evidence implicating Gfi-1 and Pim-1 in pre-T-cell differentiation steps associated with beta-selection. EMBO J 1998;17(18):5349-5359.
33. Rodel B, Tavassoli K, Karsunky H, et al: The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. EMBO J 2000;19(21):5845-5855.
34. Takeda K, Noguchi K, Shi W, et al: Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 1997;94(8):3801-3804.
35. Nefedova Y, Huang M, Kusmartsev S, et al: Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. J Immunol 2004;172(1):464-474.
36. Ju XS, Hacker C, Madruga J, et al: Towards determining the differentiation program of antigen-presenting dendritic cells by transcriptional profiling. Eur J Cell Biol 2003;82(2):75-86.
37. Cejas PJ, Carlson LM, Kolonias D, et al: Regulation of RelB expression during the initiation of dendritic cell differentiation. Mol Cell Biol 2005;25(17):7900-7916.
38. Spits H, Couwenberg F, Bakker AQ, Weijer K, Uittenbogaart CH: Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J Exp Med 2000;192(12):1775-1784.
39. Borkowski TA, Letterio JJ, Farr AG, Udey MC: A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J Exp Med 1996;184(6):2417-2422.
40. Hacker C, Kirsch RD, Ju XS, et al: Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol 2003;4(4):380-386.
41. Heinz LX, Platzer B, Reisner PM, et al: Differential involvement of PU.1 and Id2 downstream of TGFbeta1 during Langerhans-cell commitment. Blood 2006;107(4):1445-1453.
42. Kusunoki T, Sugai M, Katakai T, et al: TH2 dominance and defective development of a CD8+ dendritic cell subset in Id2-deficient mice. J Allergy Clin Immunol 2003;111(1):136-142.
43. Lee J, Kim K, Kim JH, et al: Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood 2006;107(7):2686- 2693.
44. Fiernandez-Garcia NI, Palmer HG, Garcia M, et al: 1alpha,25- Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Oncogene 2005;24(43):6533-6544.
45. Gauzzi MC, Purificato C, Conti L, Adorini L, Belardelli F, Gessani S: IRF-4 expression in the human myeloid lineage: up-regulation during dendritic cell differentiation and inhibition by 1alpha,25-dihydroxyvitamin D3. J Leukoc Biol 2005;77(6):944-947.
46. Levi BZ, Hashmueli S, Gleit-Kielmanowicz M, Azriel A, Meraro D: ICSBP/IRF-8 transactivation: a tale of protein-protein interaction. J Interferon Cytokine Res 2002;22(1):153-160.
47. Tamura T, Tailor P, Yamaoka K, et al: IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J Immunol 2005;174(5):2573-2581.
48. Suzuki S, Honma K, Matsuyama T, et al: Critical roles of interferon regulatory factor 4 in CD11bhigh CD8alpha-dendritic cell development. Proc Natl Acad Sci USA 2004;101(24):8981-8986.
49. Tsujimura H, Tamura T, Ozato K: Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J Immunol 2003;170(3):1131-1135.
50. Aliberti J, Schulz O, Pennington DJ, et al: Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells. Blood 2003;101(1):305-310.
51. Schiavoni G, Mattei F, Sestili P, et al: ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J Exp Med 2002;196(11):1415-1425.
52. Orabona C, Puccetti P,Vacca C, et al: Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 2006;107(7):2846-2854.
53. Liu J, Ma X: Interferon regulatory factor 8 regulates rantes gene transcription in cooperation with interferon regulatory factor-1, NF-kappa B and PU.1. J Biol Chem 2006;281(28):19188-19195.
54. Hanada T, Tanaka K, Matsumura Y, et al: Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. J Immunol 2005;174(7):4325-4332.
55. Hanada T, Yoshida H, Kato S, et al: Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. Immunity 2003;19(3):437-450.
56. De Smedt T, Pajak B, Muraille E, et al: Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 1996;184:1413-1424.
57. Sparwasser T, Koch ES, Vabulas RM, et al: Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 1998;28:2045-2054.
58. Cella M, ScheideggerD, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996;184:747-752.
59. Reis E, Sousa C: Activation of dendritic cells: translating innate into adaptive immunity. Curr Opin Immunol 2004;16(1):21-25.
60. Palucka KA, Banchereau J: Dendritic cells: a link between innate and adaptive immunity. J Clin Immunol 1999;19:12-25.
61. Koski GK, Lyakh LA, Cohen PA, Rice NR: CD14+ monocytes as dendritic cell precursors: diverse maturation-inducing pathways lead to common activation of NF-kappab/RelB. Crit Rev Immunol 2001;21:179-189.
62. Park SJ, Nakagawa T, Kitamura H, et al: IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol 2004;173(6):3844-3854.
63. Jackson SH, Yu CR, Mahdi RM, Ebong S, Egwuagu CE: Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling. J Immunol 2004;172(4):2307-2315.
64. Kobayashi T, Yoshimura A: Keeping DCs awake by putting SOCS1 to sleep. Trends Immunol 2005;26(4):177-179.
65. Dillon S, Agrawal A, Van Dyke T, et al: A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 2004;172(8):4733-4743.
66. Edwards AD, Manickasingham SP, Sporri R, et al: Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. J Immunol 2002;169(7):3652-3660.
67. Dalpke AH, Opper S, Zimmermann S, Heeg K: Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J Immunol 2001;166(12):7082-7089.
68. Liu E, Law HK, Lau YL: BCG promotes cord blood monocyte-derived dendritic cell maturation with nuclear Rel-B up-regulation and cytosolic I kappa B alpha and beta degradation. Pediatr Res 2003;54(1):105-112.
69. Liu E, Law HK, Lau YL: Insulin-like growth factor I promotes maturation and inhibits apoptosis of immature cord blood monocyte-derived dendritic cells through MEK and PI 3-kinase pathways. Pediatr Res 2003;54(6):919-925.
70. Uchi H, Arrighi JF, Aubry JP, Furue M, Hauser C: The sesquiterpene lactone parthenolide inhibits LPS- but not TNF-alpha-induced maturation of human monocyte-derived dendritic cells by inhibition of the p38 mitogen-activated protein kinase pathway. J Allergy Clin Immunol 2002;110(2):269-276.
71. Xie J, Qian J, Wang S, Freeman ME 3rd, Epstein J, Yi Q: Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38. J Immunol 2003;171(9):4792-4800.
72. Valentinis B, Bianchi A, Zhou D, et al: Direct effects of polymyxin B on human dendritic cells maturation. The role of IkappaB-alpha/NF-kappaB and ERK1/2 pathways and adhesion. J Biol Chem 2005;280(14):14264-14271.
73. Yanagawa Y, Iijima N, Iwabuchi K, Onoe K: Activation of extracellular signal-related kinase by TNF-alpha controls the maturation and function of murine dendritic cells. J Leukoc Biol 2002;71(1):125-132.
74. Puig-Kroger A, Relloso M, Fernandez-Capetillo O, et al: Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells. Blood 2001;98(7):2175-2182.
75. Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C: A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol 2001;166(6):3837-3845.
76. Yu Q, Kovacs C, Yue FY, Ostrowski MA: The role of the p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and phosphoinositide-3-OH kinase signal transduction pathways in CD40 ligand-induced dendritic cell activation and expansion of virus-specific CD8+ T cell memory responses. J Immunol 2004;172(10):6047-6056.
77. Flohe SB, Bruggemann J, Lendemans S, et al: Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J Immunol 2003;170(5):2340-2348.
78. Kobayashi T, Walsh PT, Walsh MC, et al: TRAF6 is a critical factor for dendritic cell maturation and development. Immunity 2003;19(3):353-363.
79. Andreae S, Piras F, Burdin N, Triebel F: Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223). J Immunol 2002;168(8):3874-3880.
80. Andreae S, Buisson S, Triebel F: MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood 2003;102(6):2130-2137.
81. Tas SW, de Jong EC, Hajji N, et al: Selective inhibition of NF-kappaB in dendritic cells by the NEMO-binding domain peptide blocks maturation and prevents T cell proliferation and polarization. Eur J Immunol 2005;35(4):1164-1174.
82. Rescigno M, Piguet V, Valzasina B, et al: Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J Exp Med 2000;192(11):1661-1668.
83. Guo Z, Zhang M, An H, et al: Fas ligation induces IL-1beta-dependent maturation and IL-1beta-independent survival of dendritic cells: different roles of ERK and NF-kappaB signaling pathways. Blood 2003;102(13):4441-4447.
84. Cook DN, Prosser DM, Forster R, et al: CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 2000;12(5):495-503.
85. Sozzani S, Sallusto F, Luini W, et al: Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol 1995;155:3292-3295.
86. Foti M, Granucci F, Aggujaro D, et al: Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site. Int Immunol 1999;11(6):979-986.
87. Sallusto F, Palermo B, Lenig D, et al: Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 1999;29(5):1617-1625.
88. Zlotnik A, Morales J, Hedrick JA: Recent advances in chemokines and chemokine receptors. Crit Rev Immunol 1999;19(1):1-47.
89. Sica A, Saccani A, Borsatti A, et al: Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human lymphocytes. J Exp Med 1997;185:969-974.
90. Dieu MC, Vanbervliet B, Vicari A, et al: Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998;188(2):373-386.
91. Fainaru O, Shseyov D, Hantisteanu S, Groner Y: Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease. Proc Natl Acad Sci USA 2005;102(30):10598-10603.
92. Dominguez-Soto A, Puig-Kroger A, Vega MA, Corbi AL : PU.1 regulates the tissue-specific expression of dendritic cell-specific intercellular adhesion molecule (ICAM)-3-grabbing nonintegrin. J Biol Chem 2005;280(39):33123-33131.
93. Guo Z, Zhang M, Tang H, Cao X: Fas signal links innate and adaptive immunity by promoting dendritic cell secretion of CC and CXC chemokines. Blood 2005;106(6):2033-2041.
94. Tsujimura H, Tamura T, Kong HJ, et al: Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J Immunol 2004;172(11):6820-6827.
95. Takauji R, Iho S, Takatsuka H, et al: CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors. J Leukoc Biol 2002;72(5):1011-1019.
96. Uematsu S, Sato S, Yamamoto M, et al: Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction. J Exp Med 2005;201(6):915-923.
97. Lugo-Villarino G, Maldonado-Lopez R, Possemato R, Penaranda C, Glimcher LH: T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc Natl Acad Sci USA 2003;100(13):7749- 7754.
98. Artis D, Kane CM, Fiore J, et al: Dendritic cell-intrinsic expression of NF-kappa B1 is required to promote optimal Th2 cell differentiation. J Immunol 2005;174(11):7154-7159.
99. Ashany D, Savir A, Bhardwaj N, Elkon KB: Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. J Immunol 1999;163(10):5303- 5311.
100. Rescigno M, Piguet V, Valzasina B, et al: Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J Exp Med 2000;192(11):1661-1668.
101. Lundqvist A, Nagata T, Kiessling R, Pisa P: Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L). Cancer Immunol Immunother 2002;51(3):139-144.
102. Nat R, Radu E, Regalia T, Popescu LM: Apoptosis in the immune system: 1. Fas-induced apoptosis in monocytes-derived human dendritic cells. J Cell Mol Med 2002;6(2):223-234.
103. McLellan AD, Terbeck G, Mengling T, et al: Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development. Cell Death Differ 2000;7(10):933-938.
104. Hoves S, Krause SW, Halbritter D, et al: Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC. J Immunol 2003;170(11):5406-5413.
105. Chen A, Xu H, Choi Y, Wang B, Zheng G: TRANCE counteracts FasL-mediated apoptosis of murine bone marrow-derived dendritic cells. Cell Immunol 2004;231(1-2):40-48.
106. Kriehuber E, Bauer W, Charbonnier AS, et al: Balance between NF-kappaB and JNK/AP-1 activity controls dendritic cell life and death. Blood 2005;106(1):175-183.